Velocity BioGroup, LLC
Gary Grazioso serves as the Chief Commercial Officer at Velocity BioGroup, LLC since April 2025. Previously, from May 2023 to January 2025, Gary was the President and CEO of eMed Digital Healthcare, leading efforts to democratize healthcare with a digital point-of-care platform. At Quest Diagnostics, from March 2012 to June 2023, Gary held multiple roles, including Vice President and General Manager of Specialty Diagnostics and Emerging Markets, and Vice President of U.S. Commercial Operations, overseeing a range of strategic responsibilities from national contract management to sales training development. Early career positions included Vice President of Pharmaceutical Data Services at Managed Health Care Associates, Inc., and various leadership roles at Organon and Ortho Biotech, focusing on sales operations and business analysis.
This person is not in any teams
This person is not in any offices
Velocity BioGroup, LLC
If the government pays, the feds usually have a role in it. What that means for you is that laws and regulations, centralized decision-making and cost-driven access constraints all play a critical role in market access. We know our way around Federal Markets to ensure that you will too. Velocity BioGroup is a strategic group of long-time business executives in the pharmaceutical, biologics, medical devices and Federal Markets, with very high-level relationships in the commercial and government payer world, public relations and advocacy communities. The primary function of the Velocity BioGroup team is to support your organization in framing a compelling formula for the success of your key products introduced in the market.